Detil Data Ivosidenib

     
NAME : Ivosidenib
BOBOT : 582.97
RUMUS : C28H22ClF3N6O3
THERAPEUTIC INDC : Ivosidenib is approved for use in the treatment of relapsed or refractory AML with a susceptible IDH1 mutation as detected by an FDA-approved test ...
CATEGORIES : Cytochrome P-450 CYP2B6 Inducers / Cytochrome P-450 CYP2C8 Inducers / Cytochrome P-450 CYP2C9 Inducers / Cytochrome P-450 CYP3A Inducers / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Enzyme Inducers / OAT3 Inhibitors / P-glycoprotein/ABCB1 Inhibitors / P-glycoprotein/ABCB1 Substrates / QTc Prolonging Agents
STRUCTURE :